In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
Open accessThe DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Several CRISPR-Cas9 orthologues have been used for genome editing. Here, we present the smallest Cas9 orthologue characterized to date, derived from Campylobacter jejuni (CjCas9), for efficient genome editing in vivo . After determining protospacer-adjacent motif (PAM) sequences and optimizing single-guide RNA (sgRNA) length, we package the CjCas9 gene, its sgRNA sequence, and a marker gene in an all-in-one adeno-associated virus (AAV) vector and produce the resulting virus at a high titer. CjCas9 is highly specific, cleaving only a limited number of sites in the human or mouse genome. CjCas9, delivered via AAV, induces targeted mutations at high frequencies in mouse muscle cells or retinal pigment epithelium (RPE) cells. Furthermore, CjCas9 targeted to the Vegfa or Hif1a gene in RPE cells reduces the size of laser-induced choroidal neovascularization, suggesting that in vivo genome editing with CjCas9 is a new option for the treatment of age-related macular degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Smaller genome editing proteins, such as the S. aureus Cas9, C. jejuni Cas9 and newly identified CRISPR-Cas enzymes, may circumvent this issue 23,61-65 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [65]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The downregulation was linked to a decrease in spot size on morphology of the laser-induced choroidal neovascularization (wet AMD model) but not on retinal function measured by electroretinogram (ERG) [221].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [221]
The cited source says what the claim attributes to it.
In the citing paper
“Fonfara et al. previously reported the optimal in vitro PAM site for CjCas9 to be 5′-NNNNACA”
From Viral Delivery Systems for CRISPR (2019) · cites this paper as [72]
The cited source says what the claim attributes to it.
In the citing paper
“In February 2017, Kim et al. presented efficient in vivo genome editing using the smallest Cas9 orthologue (2.95 kb) that has been characterized as of February 2017: Campylobacter jejuni (CjCas9) [72].”
From Viral Delivery Systems for CRISPR (2019) · cites this paper as [72]
The cited source says what the claim attributes to it.
In the citing paper
“In February 2017, Kim et al. presented efficient in vivo genome editing using the smallest Cas9 orthologue (2.95 kb) that has been characterized as of February 2017: Campylobacter jejuni (CjCas9) [72].”
From Viral Delivery Systems for CRISPR (2019) · cites this paper as [72]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Bae, S., Park, J., & Kim, J.-S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu048 · Cited by 2,339
Self-citationRNA-programmed genome editing in human cells
Jinek, M., East, A., Cheng, A., Lin, S., Ma, E., & Doudna, J. (2013) · eLife · doi:10.7554/elife.00471 · Cited by 2,098
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
Cho, S. W., Kim, S., Kim, J. M., & Kim, J.-S. (2013) · Nature Biotechnology · doi:10.1038/nbt.2507 · Cited by 1,863
Self-citationStructural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease
Anders, C., Niewoehner, O., Duerst, A., & Jinek, M. (2014) · Nature · doi:10.1038/nature13579 · Cited by 1,323
Cited by
Items 601–700 of 730
Precision Cas9 Genome Editing in vivo with All-in-one, Self-targeting AAV VectorsPreprint
Ibraheim, R., Tai, P. W. L., Mir, A., Javeed, N., Wang, J., Rodríguez, T., Nelson, S. J., Khokhar, E. S., Mintzer, E., Maitland, S. A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.09.333997 · Cited by 3
Rabinowitz, R., Darnell, R., & Offen, D. (2019) · Research Square · doi:10.21203/rs.2.9413/v1 · Cited by 2
Hijacking and recording intracellular RNAs in human cells using eukaryotic reprogrammed tracrRNAsPreprint
Lee, S.-H., Park, J., Jung, C., & Bae, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.28.620760 · Cited by 2
Molecular engineering and dynamic activation mechanism of a PAM-flexible compact CRISPR-Cas9Preprint
Nureki, O., Nakagawa, R., Omura, S. N., Kajimoto, S., Okazaki, S., Hirano, H., Yamashita, K., Nishimasu, H., Ishiguro, S., Mori, H., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4619764/v1 · Cited by 2
Computational Tools for Target Design and Analysis
Hwang, G., & Bae, S. (2022) · Wiley eBooks · doi:10.1002/9781119671404.ch5 · Cited by 1
Type II CRISPR–Cas System Nucleases: A Pipeline for Prediction and In Vitro Characterization
Vasileva, A., Aliukas, S. A., Selkova, P., Arseniev, A., Chernova, V. E., Musharova, O. S., Klimuk, E. I., Khodorkovskii, M. A., & Severinov, K. (2023) · Molecular Biology · doi:10.1134/s0026893323030147 · Cited by 1
Nano-Polymers as Cas9 Inhibitors
Chepurna, O. M., Chatterjee, A., Li, Y., Ding, H., Murali, R., Black, K. L., & Sun, T. (2025) · Polymers · doi:10.3390/polym17030417 · Cited by 1
Mosterd, C., & Moineau, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052005 · Cited by 1
Eom, K.-H., Yum, S., Gim, G., Kim, Y.-C., Moon, B., & Jang, G. (2025) · Theriogenology · doi:10.1016/j.theriogenology.2025.117676 · Cited by 1
CRISPR/Cas9‐Mediated Gene Knockout in Cereal Crops
Pramanik, D., Wang, K., & Lee, K. (2025) · Current Protocols · doi:10.1002/cpz1.70210 · Cited by 1
Self-citationZhao, R., Zhu, J., Wang, J., Wang, D., Liu, X. S., Han, L., & Li, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110681 · Cited by 1
In vivo genome editing with a novel Cj4Cas9
Wang, T., Tian, Y., Yin, R., Li, M., Luo, J., Yang, Y., Zhang, C., Chen, H., Wang, Y., & Lu, D. (2025) · Communications Biology · doi:10.1038/s42003-025-09430-9 · Cited by 2
Therapeutic Gene Editing: DNA Repair Pathways, Emerging Editors, and Clinical Progress
Tsai, L., Xiong, Y., Liu, D., Yang, D., Zhang, J., Xu, J., Han, R., & Chen, Y. (2026) · iNew Medicine · doi:10.1002/inm3.70018 · Cited by 1
Application of compact CRISPR/Cas nucleases for citrus genome editing
Zhu, Y., Zhang, J., Yunqiang, R., Lei, T., Li, S., Cao, L., Zou, X., He, Y., Li, Q., Chen, S., et al. (2026) · Transgenic Research · doi:10.1007/s11248-026-00481-0 · Cited by 1
Mir, M. Y., Seh, B. A., Rafiq, K., & Légrádi, Á. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062845 · Cited by 1
Epigenome editing strategies: technological progress and in vivo applications
Morita, S., Horii, T., & Hatada, I. (2026) · BMC Methods · doi:10.1186/s44330-026-00069-4 · Cited by 1
Mundada, A. R., Badikol, A. R., & Mangu, K. (2026) · Neurogenetics · doi:10.1007/s10048-026-00921-3 · Cited by 1
Li, T.-T., Chen, X., Wang, F., Tang, Y. A., Sim, M., Xiao, L., Jin, W., Shi, H., Ma, J. Y., Yang, X., et al. (2026) · Nature Biotechnology · doi:10.1038/s41587-026-03269-z · Cited by 1
A Review on CRISPR/ Cas9: A Molecular Approach to Genome Editing
Singh, M., Singh, D., Suyal, D. C., Mehra, A., Tripathi, V., Bhasin, S., Rai, P. K., Saxena, R., & Ilyas, A. (2021) · Invertis Journal of Renewable Energy · doi:10.5958/2454-7611.2021.00003.5 · Cited by 1
X-Tracting a New CRISPR-Cas Genome-Editing Platform from Metagenomic Data Sets
Sontheimer, E. J. (2019) · The CRISPR Journal · doi:10.1089/crispr.2019.29061.ejs · Cited by 1
Bai, X., Zhang, S., Gan, L., Lü, W., & Li, J. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108392 · Cited by 1
Harnessing CRISPR-Cas system diversity for gene editing technologies
McKay, A., & Burgio, G. (2021) · Journal of Biomedical Research · doi:10.7555/jbr.35.20200184 · Cited by 1
Jo, D. H., Kim, J. H., & Kim, J. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817876-8.00001-2 · Cited by 1
Self-citationYang, F., Zhang, H., Cai, S., Imtiaz, K., Li, M., Wang, M., Liu, Y., Xue, F., Zhang, L., & Gu, F. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0056 · Cited by 1
Expanding the Scope of Base Editing in Crops Using Cas9 Variants
Mishra, R., Mushtaq, M., & Joshi, R. K. (2022) · Springer eBooks · doi:10.1007/978-981-19-0600-8_8 · Cited by 1
Genome Editing and Fatty Liver
Hayat, U., Siddiqui, A. A., Farhan, M. L., Haris, A., & Hameed, N. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-5642-3_13 · Cited by 1
Turning Tables for CRISPR/Cas9 Editing System: From Scratch to Advanced Delivery Platforms
Chira, S., Nutu, A. M., Bica, C., Pop, L., Gherman, M., Angheluță, M.-D., & Berindan‐Neagoe, I. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_292-1 · Cited by 1
Exploration of Genome Editing Tools for microRNA Engineering in Plants
Xu, H. (2023) · Wiley eBooks · doi:10.1002/9781394183913.ch15 · Cited by 1
Emerging strategies to minimize the off-target effects in CRISPR/Cas9 system
Ouyang, C. (2024) · International Conference on Biological Engineering and Medical Science (ICBioMed) · doi:10.1117/12.3013214 · Cited by 1
Cas9 Cis/Trans Cleavage Mechanisms: Cross-System CRISPR Insights and Diagnostic Applications
Li, X., Chen, Y., Huang, L., Chen, J., & Liu, L. (2025) · Health and Metabolism · doi:10.53941/hm.2025.100021 · Cited by 1
Deneault, É. (2025) · Genetics. · doi:10.5772/intechopen.1013143 · Cited by 1
Vasileva, A., Abramova, M., Selkova, P., Arseniev, A. N., Musharova, O. S., Malysheva, P. V., Demkina, A., Khodorkovskii, M. A., & Severinov, K. (2025) · The CRISPR Journal · doi:10.1177/25731599251404417 · Cited by 2
CRISPR/CAS9-Mediated Gene Editing in Herda Equine
Hawkes, J. R. (2020) · Digital Commons - USU (Utah State University) · doi:10.26076/b469-3b19 · Cited by 3
Mak, J. K., & Mináry, P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.08.681228 · Cited by 1
High-throughput in vitro specificity profiling of natural and high-fidelity CRISPR-Cas9 variantsPreprint
Murugan, K., Seetharam, A. S., Severin, A. J., & Sashital, D. G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.12.091991 · Cited by 1
Gene Editing of Stem Cells to Model and Treat Disease
Hollywood, J. A., Sanz, D. J., Davidson, A. J., & Harrison, P. T. (2018) · Current Stem Cell Reports · doi:10.1007/s40778-018-0140-x
Clinical Genetics of Vitelliform Macular Dystrophy: An Asian Perspective
Park, S. W., Yoon, C. K., Ma, D. J., Park, U. C., & Yu, H. G. (2018) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-981-13-0884-0_21
Self-citationA novel CRISPR-Cas9 platform with divergent targeting capabilities
Chatterjee, P. (2018)
Development of therapeutic genome engineering in laminin-α2-deficient congenital muscular dystrophy
Kemaladewi, D. U., & Cohn, R. D. (2019) · Emerging Topics in Life Sciences · doi:10.1042/etls20180059
Base Editing: A New Approach to Genome Editing
Kim, Y. B. (2018) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Directed evolution of Cas9 for mammalian genome editing
Hu, J. H. (2018) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Expanding the Capabilities of Genome Editing
Rees, H. A. (2019) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Computational analysis of DNA and RNA editing in human cells
Srinivasan, H. (2019) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/136576
Gene editing in PRKDC severe combined immunodeficiency and ataxia telangiectasia
Prakash, V. (2017) · Cited by 1
Kessy, E. (2019) · Montana State University ScholarWorks (Montana State University)
Interrogating genome function using CRISPR tools: a narrative review
Ren, X., Takagi, M. A., & Shen, Y. (2020) · Journal of Bio-X Research · doi:10.1097/jbr.0000000000000066
CRISPR/Cas9によるゲノム編集技術の進展と作物への応用: 発展し続けるCRISPR/Cas9を用いたゲノム編集技術
亮, 遠., 秀隆, 賀., & Toki, S. (2018) · KAGAKU TO SEIBUTSU · doi:10.1271/kagakutoseibutsu.56.759
Genome editing and RNA interference technologies in plants
Tamang, T. M., Kakeshpour, T., Hu, Y., Peng, Z., & Wu, Q. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821120-5.00001-8
Choosing a nuclease, guide RNA, and repair template
Musunuru, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823484-6.00003-7
Generating Isogenic Models of Li-Fraumeni Syndrome and Restoring p53 using CRISPR
Tran, J. (2020) · TSpace (University of Toronto)
Arnesen, J. A., Nielsen, J. B., Kildegaard, H. F., & Borodina, I. (2021) · Metabolic Engineering · doi:10.1002/9783527823468.ch10
Mechanisms to investigate the nervous system : genetic engineering with adeno-associated viruses
Torregrosa, T. (2020) · Digital Repository Service (Northeastern University) · doi:10.17760/d20382808
Extension and Improvement of CRISPR-Based Technology
Zhang, Z., Wang, P., & Liu, J. (2022) · Springer eBooks · doi:10.1007/978-981-16-8504-0_3
Karyotype diversification in colorectal cancer
Bollen, Y. (2022) · doi:10.3990/1.9789036553506
Šviković, S. (2022) · Wiley eBooks · doi:10.1002/9781119671404.ch3
Efficient in vitro and in vivo self-repression of SpCas9 gene using a molecular Hara-Kiri method.Preprint
Iyombe-Engembe, J.-P., Duchêne, B. L., Rousseau, J., Ouellet, D. L., Cherif, K., Guyon, A., & Tremblay, J. P. (2022) · Research Square · doi:10.21203/rs.3.rs-1353802/v1
Utilizing CRISPR/Cas9 Technologies for in vivo Disease Modeling and Therapy
Badertscher, L., & Porritt, M. J. (2022) · Wiley eBooks · doi:10.1002/9781119671404.ch7
Delivery and Formulation Methods for Therapeutic Genome Editing
Blenke, E. O., & Krishnamurthy, V. R. (2022) · Wiley eBooks · doi:10.1002/9781119671404.ch18
Fan, M., Berkhout, B., & Herrera-Carrillo, E. (2022) · Research Square · doi:10.21203/rs.3.rs-1458483/v1
Emerging Technologies for Genome Editing
Peterka, M. (2022) · Wiley eBooks · doi:10.1002/9781119671404.ch22
Faculty Opinions recommendation of The CRISPR tool kit for genome editing and beyond.
Warming, S. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733248495.793546194
Review of Cell and Molecular Biology
Elder, K. T., & Dale, B. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108611633.002
Engineering Viral Vectors for CRISPR-Cas Mediated Genome Editing in Plants
Uranga, M. (2022) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/183374
Genome Editing Is Revolutionizing Crop Improvement
Mishra, R., Joshi, R. K., & Zhao, K. (2022) · Springer eBooks · doi:10.1007/978-981-19-0600-8_1
Genome Editing in Crops Via Homology-Directed Repair Using a Geminivirus-Based CRISPR/Cas9 System
Hameed, A., Faazal, B., Awais, M., & Naveed, A. (2022) · Springer eBooks · doi:10.1007/978-981-19-0600-8_6
Molecular Mechanisms of Type II CRISPR ‐ Cas Systems
Karvelis, T., & Šikšnys, V. (2022) · Wiley eBooks · doi:10.1002/9781683673798.ch4
Genome Editing with CRISPR‐Cas Systems
Lotfy, P., & Hsu, P. D. (2022) · Wiley eBooks · doi:10.1002/9781683673798.ch11 · Cited by 1
CRISPR/Cas9, a decade of genome editing tools to fix the DNA
Santos, L. (2022) · Science Reviews Biology · doi:10.57098/scirevs.biology.1.1.3
Wada, N., Osakabe, Y., & Osakabe, K. (2022) · CABI eBooks · doi:10.1079/9781789247534.0015
CRISPR-Cas9 mediated endogenous utrophin upregulation improves Duchenne Muscular DystrophyPreprint
Guiraud, S., Dastidar, S., Mazed, F., Amor, F., Ralu, M., Cian, A. D., Richard, I., Ronzitti, G., Tedesco, F. S., & Amendola, M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.18.536394
Prokaryotic genome editing based on the subtype I-B-Svi CRISPR-Cas systemPreprint
Tong, W., Yong, D.-X., Xu, X., Qiu, C.-H., Zhang, Y., Yang, X., Xia, T., Liu, Q.-Y., Cao, S.-L., Yan, S., et al. (2023) · arXiv (Cornell University) · doi:10.48550/arxiv.2305.05093
Type II CRISPR-Cas System Nucleases: a Pipeline for Prediction and in vitro Characterization
Васильева, А. А., Aliukas, S. A., Selkova, P., Arseniev, A. N., Chernova, V. E., Musharova, O. S., Klimuk, E. I., Khodorkovskii, M. A., & Severinov, K. (2023) · Molecular Biology · doi:10.31857/s0026898423030163
CRISPR-Cas9: A new approach to genome editing and clinical treatment
Meša, I. (2020) · Bioengineering Studies · doi:10.37868/bes.v3i1.id215
History, Development and Characteristics of CRISPR-Cas SystemPreprint
Nazir, T., Mirza, H. A., & Taha, N. (2024) · Preprints.org · doi:10.20944/preprints202401.0591.v1
The Applications of Genome Editing in the Management of Cancer: A Narrative Overview
Al-Janabi, I. I. (2024) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v6i1.503
Transient CRISPR-Cas delivery for therapeutic gene editing in the retina
Botto, C. (2022) · theses.fr (ABES) · doi:10.70675/b0c6037fz0240z4844z9036z7867f920dadc
Edition génomique de la lignée B en vue de la sécrétion d'anticorps thérapeutiques
Cahen, M. (2022) · theses.fr (ABES) · doi:10.70675/07cca0e4ze8f2z4436z9d2dzea346a6670e9
Stieger, K., & Lorenz, B. (2024) · Springer eBooks · doi:10.1007/978-3-031-35055-9_15
Structure and Function of CRISPR-Cas Effector Nucleases
Nishimasu, H. (2017) · Kyokugen Kankyo Seibutsu Gakkaishi · doi:10.3118/extremophiles.16.2_59 · Cited by 1
Qian, Y., Wang, D., Niu, W., Zhao, D., Li, J., Liu, Z., Gao, X., Han, Y., Lai, L., & Li, Z. (2023) · Figshare · doi:10.6084/m9.figshare.23665132
Gene Expression and Editing in Mammalian Retinal Ganglion Cells
Tran, N. M., Xu, X., Qi, L. S., & Hu, Y. (2024) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-981-99-4436-1_19 · Cited by 1
CRISPR/Cas9-based genetic engineering for translational research in neurological disorders
Megagiannis, P., Rouleau, G. A., & Zhou, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19041-4.00021-2
Rational Design of Enhanced Nme2Cas9 and Nme2 Smu Cas9 Nucleases and Base EditorsPreprint
Bamidele, N., Ansodaria, A. V., Chen, Z., Cheng, H., Panwala, R., Jazbec, E., & Sontheimer, E. J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.30.620986
CRISPR-Cas: A Technology for Enhancing Commercially Valuable Traits in Industrial Crops
Kumar, A. (2025) · Sustainable landscape planning and natural resources management · doi:10.1007/978-3-031-75937-6_4
Belato, H. B., Knight, A. L., D’Ordine, A. M., Pindi, C., Fan, Z.-Q., Luo, J., Palermo, G., Jogl, G., & Lisi, G. P. (2025) · eLife · doi:10.7554/elife.99275.2
CRISPR plants for studying functional genomics: Methods and applications
Uranga, M., Martín‐Hernández, A. M., Pasin, F., & Storme, N. D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24135-2.00002-5 · Cited by 1
Belato, H. B., Knight, A. L., D’Ordine, A. M., Pindi, C., Fan, Z.-Q., Luo, J., Palermo, G., Jogl, G., & Lisi, G. P. (2025) · eLife · doi:10.7554/elife.99275.3
“Glutaminolysis Fuels Reactive Astrocytes, Exacerbating Amyloid Pathology in Alzheimer’s Disease”Preprint
Devi, S. S., Heese, S. L., Leray, I., & Gallardo, G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.12.658977
Rocchi, E., Magnani, F., Castellani, G., Carusillo, A., & Tarozzi, M. E. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1571023
Sen, P., Ansari, R., Chatterjee, A., Mondal, B., Sengupta, S., Ghorai, S., Bose, S., & Hazra, S. (2025) · Journal of Crop Science and Biotechnology · doi:10.1007/s12892-025-00301-7
Research progress of compact Class 2 Cas effector proteins
Liu, B., Huang, S., & ZHENG, W. (2025) · Scientia Sinica Vitae · doi:10.1360/ssv-2025-0095
Assessing Temperature-Dependent DNA Cleavage by CRISPR-Cas9
Knight, A. L., Luo, J., & Lisi, G. P. (2025) · BIO-PROTOCOL · doi:10.21769/bioprotoc.5463
Turning Tables for CRISPR/Cas9 Editing System: From Scratch to Advanced Delivery Platforms
Chira, S., Nutu, A. M., Bica, C., Pop, L., Gherman, M., Angheluță, M.-D., & Berindan‐Neagoe, I. (2025) · Springer eBooks · doi:10.1007/978-3-032-00765-0_292
Tag it and bag it: A flexible method for target DNA capture using a fusion protein of CBE with UdgX
Pan, W., Zhang, Y., Liao, X., Guo, Y.-M., & Wang, M. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.169737
Improving Gene Knock-In Efficiencies in Sheep Primary Cells Using a CRISPR/Cas9-Gal4 System
Li, Y., Wu, S. V., Wu, Y., Yuan, Y., Zhao, Y., Teng, M., Zhang, W., Wang, J., & Qiu, Y. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47110899
Kwon, J., Kim, M., Hwang, W., Jo, A., Hwang, G.-H., Jung, M., Kim, U. G., Cui, G., Kim, H. S., Eom, J.-H., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601900
Self-citationAdditional file 1 of Comparison of DNA targeting CRISPR editors in human cells
Huang, H., Lv, W., Li, J., Huang, G., Tan, Z., Hu, Y., Ma, S., Zhang, X., Huang, L., & Lin, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26561671
Tumor-targeted delivery of Cas9 mRNA and sgRNA against KRAS-mutated lung cancer
Chen, S. (2024) · doi:10.5282/edoc.34484 · Cited by 1
Kwon, J., Kim, M., Hwang, W., Jo, A., Hwang, G.-H., Jung, M., Kim, U. G., Cui, G., Kim, H. S., Eom, J.-H., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601891
Self-citation
Metadata
- Authors
- Kim, E., Koo, T., Park, S. W., Kim, D., Kim, K., Cho, H.-Y., Song, D. W., Lee, K. J., Jung, M. H., Kim, S., Kim, J. H., Kim, J. H., & Kim, J.-S.
- Affiliations
- Institute for Basic Science (KR)
- Seoul National University (KR)
- ToolGen (South Korea) (KR)
- Corresponding author
- Kim, Jeong Hun
- ORCID
- Venue
- Nature Communications
- Published
- 2017-02-21
- Volume
- 8
- Issue
- 1
- Pages
- 14500-14500
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5473640
- OpenAlex
- W2590764628
- Cited by
- 715
- References
- 38
- Citations by year
- 2026: 24 · 2025: 68 · 2024: 68 · 2023: 81 · 2022: 114 · 2021: 94 · 2020: 87 · 2019: 77 · 2018: 66 · 2017: 36
- FWCI
- 29.72
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Funders
- National Research Foundation (NRF-2015M3A9E6028949)
- Ministry of Science, ICT and Future Planning (NRF-2015M3A9E6028949, IBS-R021-D1, 2015M3A9E6028949)
- Korea Health Industry Development Institute (HI16C0426)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- in vivo gene editing, adeno-associated virus vectors, single guide RNA, protospacer adjacent motif, retinal pigment epithelium, choroidal neovascularization, age-related macular degeneration, VEGF-A, HIF1A, targeted mutagenesis
- MeSH terms
- Gene Editing, Dependovirus, Animals, Bacterial Proteins, Cells, Cultured, Endonucleases, Humans, Male, Mice, Inbred C57BL, Campylobacter jejuni, Choroidal Neovascularization, Vascular Endothelial Growth Factor A, Retinal Pigment Epithelium, HEK293 Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.